Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för temozolomide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2013-02-07

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.

Faivre C, Barbolosi D, Pasquier E, André N.

Cancer Chemother Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s00280-013-2095-z

Bibliografisk träff 2013-02-02

The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.

Park CK, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW.

J Neurooncol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s11060-013-1060-3

Bibliografisk träff 2013-02-01

Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Sherriff J, Tamangani J, Senthil L, Cruickshank G, Spooner D, Jones B, Brookes C, Sanghera P.

Br J Radiol · research-article; journal article · DOI 10.1259/bjr.20120414

Bibliografisk träff 2013-01-29

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma.

Yamaki T, Suenaga Y, Iuchi T, Alagu J, Takatori A, Itami M, Araki A, Ohira M, Inoue M, Kageyama H, Yokoi S, Saeki N, Nakagawara A.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep01160

Bibliografisk träff 2013-01-17

Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program.

Keir ST, Maris JM, Reynolds CP, Kang MH, Kolb EA, Gorlick R, Lock R, Carol H, Morton CL, Wu J, Kurmasheva RT, Houghton PJ, Smith MA.

Pediatr Blood Cancer · research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/pbc.24368

Bibliografisk träff 2012-12-27

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.

Thomas RP, Recht L, Nagpal S.

Clin Pharmacol · review-article; journal article · DOI 10.2147/cpaa.s26586

Bibliografisk träff 2012-12-20

Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.

Gutenberg A, Bock HC, Reifenberger G, Brück W, Giese A.

Acta Neurochir (Wien) · comparative study; journal article · DOI 10.1007/s00701-012-1583-y

Bibliografisk träff 2012-12-12

Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.

Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S.

Cancer Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.canlet.2012.12.005

Bibliografisk träff 2012-07-19

Temozolomide and unusual indications: review of literature.

Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, Durando X.

Cancer Treat Rev · review; journal article · DOI 10.1016/j.ctrv.2012.06.002

Bibliografisk träff 2012-06-11

The efficacy of temozolomide for recurrent glioblastoma multiforme.

Chen C, Xu T, Lu Y, Chen J, Wu S.

Eur J Neurol · meta-analysis; research support, non-u.s. gov't; review; journal article · DOI 10.1111/j.1468-1331.2012.03778.x